Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples

KRAS mutations are common in colorectal cancer (CRC). In this setting, mutation status determination in circulating-free DNA from blood samples (liquid biopsy) has been shown to be a viable alternative to tissue testing. The objective of this study was to compare the sensitivity of two liquid biopsy...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivancos, Ana, Aranda, Enrique, Benavides, Manuel, Élez, Elena, Gómez-España, Maria Auxiliadora, Toledano, Marta, Alvarez, Martina, Parrado, Maria Rosario Chica, García-Barberán, Vanesa, Diaz-Rubio, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586620/
https://www.ncbi.nlm.nih.gov/pubmed/31222012
http://dx.doi.org/10.1038/s41598-019-45616-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586620/
https://www.ncbi.nlm.nih.gov/pubmed/31222012
http://dx.doi.org/10.1038/s41598-019-45616-y

Ejemplares similares